Vertigenics Under Review: Natural Vertigo Breakthrough with Clinically-Researched Ingredients

New York City, April 25, 2025 (GLOBE NEWSWIRE) — In This Article, You’ll Discover: What vertigo really is and why it’s more than just feeling dizzy The biological and neurological causes of balance disorders Why conventional vertigo treatments often fall short How Vertigenics offers natural support for inner ear health and cognitive clarity A detailed review of Vertigenics’ clinically-researched ingredients How Vertigenics may assist with blood flow, nerve health, and...

Paul Mueller Company Announces Its First Quarter Earnings of 2025

SPRINGFIELD, Mo., April 25, 2025 (GLOBE NEWSWIRE) — Paul Mueller Company (OTC: MUEL) today announced earnings for the first quarter ended March 31, 2025.                    ...

Flexigenics Under Review: Proven Joint Health Ingredients for Supporting Ease of Movement

New York City, April 25, 2025 (GLOBE NEWSWIRE) — In This Article, You’ll Discover: What causes joint discomfort and why it’s becoming increasingly common How inflammation, calcium buildup, and cartilage deterioration affect mobility Why...

New Providence Acquisition Corp. III Completes $300,150,000 Initial Public Offering

Palm Beach, FL, April 25, 2025 (GLOBE NEWSWIRE) — New Providence Acquisition Corp. III (the “Company”) announced today the closing of its initial public offering of 30,015,000 units, which includes 3,915,000 units issued pursuant...

Best Online Casino Games 2025: Black Lotus Top for Real Money Casino Games

New York City, April 25, 2025 (GLOBE NEWSWIRE) — Black Lotus Casino, an online gambling platform that offers real-money gaming, was recently named the top platform for real-money online casino games in 2025. One...

Rezolute, Inc. Announces Closing of Underwritten Offering

NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) — Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage biopharmaceutical company committed to developing novel, transformative therapies for serious rare diseases, today announced the closing...

Malibu Boats, Inc. Announces Earnings Release Date and Conference Call Information for Third Quarter Fiscal 2025 Financial Results

LOUDON, Tenn., April 25, 2025 (GLOBE NEWSWIRE) — Malibu Boats, Inc. (Nasdaq: MBUU) announced today that it will release its third quarter fiscal 2025 financial results on Thursday, May 8, 2025, before the market...

Zenas BioPharma Investors Encouraged to Contact Cohen Milstein to Lead ZBIO IPO Stock Drop Securities Class Action

WASHINGTON, April 25, 2025 (GLOBE NEWSWIRE) — Retail investors who purchased shares of Zenas BioPharma, Inc. (NASDAQ: ZBIO) in the company’s September 2024 initial public offering may have the chance to lead a securities...

Arbor Realty Trust Schedules First Quarter 2025 Earnings Conference Call

UNIONDALE, N.Y., April 25, 2025 (GLOBE NEWSWIRE) — Arbor Realty Trust, Inc. (NYSE: ABR), today announced that it is scheduled to release first quarter 2025 financial results before the market opens on Friday, May...

Park National Corporation reports financial results for first quarter 2025

NEWARK, Ohio, April 25, 2025 (GLOBE NEWSWIRE) — Park National Corporation (Park) (NYSE American: PRK) today reported financial results for the first quarter of 2025. Park’s board of directors declared a quarterly cash dividend...

New Data at AACR Annual Meeting Highlights Use of DecisionDx®-Melanoma to Identify Early-Stage Melanoma Patients at High Risk of Distant Metastasis

FRIENDSWOOD, Texas, April 25, 2025 (GLOBE NEWSWIRE) — Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, will share new research intended to improve the care of...

Amplify Energy and Juniper Capital Announce Termination of Merger Agreement

HOUSTON, April 25, 2025 (GLOBE NEWSWIRE) — Amplify Energy Corp. (NYSE: AMPY) (“Amplify” or the “Company”) announced today that the Company and Juniper Capital Advisors, L.P. (“Juniper”) have entered into a mutual termination agreement...

Epsilon Energy Ltd. Schedules First Quarter 2025 Earnings Release and Conference Call

HOUSTON, April 25, 2025 (GLOBE NEWSWIRE) — Epsilon Energy Ltd. (“Epsilon” or the “Company”) (NASDAQ: EPSN) today announced that it will issue its first quarter 2025 earnings release on Wednesday, May 14, 2025 after...

Prelude Announces Presentations at 2025 AACR Annual Meeting

Preclinical data elucidating the mechanism of action of PRT3789, Prelude’s first-in-class, highly selective SMARCA2 degrader currently in early clinical development Highlights from Prelude’s efforts to discover and develop selective KAT6A degraders, including preclinical data,...

Myriad Genetics Highlights MRD Clinical Validity Data at American Association for Cancer Research Annual Meeting

SALT LAKE CITY, April 25, 2025 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, announced new clinical data will be shared at the American Association...

AEON Biopharma Announces NYSE American Acceptance of Plan to Regain Listing Compliance

IRVINE, Calif., April 25, 2025 (GLOBE NEWSWIRE) — AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE: AEON), a clinical-stage biopharmaceutical company focused on developing a botulinum toxin complex for the treatment of multiple therapeutic...

Digital Ally, Inc. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Annual Report on Form 10-K

Lenexa, KS, April 25, 2025 (GLOBE NEWSWIRE) — Digital Ally, Inc. (Nasdaq: DGLY) (the “Company”) today announced it received a delinquency notification letter from Nasdaq on April 23, 2025, which indicated that the Company was not...

Molecular Partners presents new preclinical data on Radio-DARPin and Switch-DARPin programs at AACR 2025

Positive IND-enabling data on MP0712 targeting DLL3, the most advanced Radio-DARPin program in co-development with Orano Med, entering clinical development in 2025 First preclinical data of novel targeted Radio-DARPin against mesothelin (MSLN), in co-development...

NativePath Collagen Peptides Under Review: Premium Grass-Fed Pasture-Raised Collagen Protein Powder

New York City, April 25, 2025 (GLOBE NEWSWIRE) — In This Article, You’ll Discover: What collagen is and how it naturally declines with age, contributing to common aging concerns Why hydrolyzed grass-fed collagen peptides...

Best Sex Pills Under Review: How BeastForce Blood Flow Circulation Booster Supports Male Enhancement

New York City, April 25, 2025 (GLOBE NEWSWIRE) — In This Article, You’ll Discover: Why millions of men are facing a silent yet rising male vitality crisis in 2025 The real reasons behind declining...

First Central Savings Bank Reports First Quarter 2025 Results Highlighted by Net Income of $1.8 million ($0.17 EPS), Net Interest Margin Expansion by 25 basis points on a linked quarter basis and Strong Non-Interest Income

Performance Highlights Net Income: Net income for the quarter ended March 31, 2025, was $1.8 million, or $0.17 per share, compared to $1.2 million, or $0.12 per share, recorded in the prior year quarter...

Spanios and White Lion Capital LLC Announce Strategic Partnership to Accelerate Drug Development

HOUSTON, April 25, 2025 (GLOBE NEWSWIRE) — Spanios, a leader in human-derived organoid model systems, is pleased to announce a strategic partnership with White Lion Capital LLC. This collaboration empowers biotech and pharma companies...

Terra Mare Morning Restore Under Review: Ingredients List & Side Effects Complaints Examined

New York City, April 25, 2025 (GLOBE NEWSWIRE) — In This Article, You’ll Discover: What common health issues affect women as they age, including hormonal imbalance, low energy, and poor digestion Why these symptoms...

Clenbuterol Bodybuilding (Clen) Pills, Clenbuterol Dosage, Clenbuterol, Benefits, Clenbuterol Side Effects, Clenbuterol Cycles, Where to buy Clenbuterol tablet buy, ambroxol, lavizoo (CrazyBulk)

New York City, April 25, 2025 (GLOBE NEWSWIRE) — Why Do People Look for Weight Loss Pills? Many people want a leaner body and look for pills to help them achieve this. One such...

Sports.com Named Headline Event Partner for Soccerex Europe 2025 in Amsterdam

AMSTERDAM, April 25, 2025 (GLOBE NEWSWIRE) — Sports.com, the go-to platform for immersive sports content and fan engagement owned by Lottery.com Inc. (Nasdaq: LTRY, LTRYW) (“Lottery.com” or the “Company”), is proud to announce its...

First Commerce Bancorp, Inc. Reports First Quarter 2025 Results

LAKEWOOD, N.J., April 25, 2025 (GLOBE NEWSWIRE) — First Commerce Bancorp, Inc. (the “Company”), (OTC: CMRB), the holding company for First Commerce Bank (the “Bank”), today reported net income of $1.7 million and basic earnings per...

Cook County Health Cuts Ribbon on New Health Center in Bronzeville Neighborhood

Chicago, IL, April 25, 2025 (GLOBE NEWSWIRE) — Joined by Cook County leaders and patients, Cook County Health cut the ribbon on a new community health center at 467 E. 31st Street, Chicago, in the city’s Bronzeville...

Unlock Your Glutes Under Review: Best Functional Movement Training Program for a Stronger & Rounder Butt

New York City, April 25, 2025 (GLOBE NEWSWIRE) — You’ve tried the squats. You’ve done the lunges. You’ve followed the “booty band” trends and TikTok workouts that promise peach-perfect glutes in 10 days. And...

SleepFuel Under Review: Best Natural Sleep Aid Supplement using an Oral Spray Formula

New York City, April 25, 2025 (GLOBE NEWSWIRE) — For some, falling asleep takes hours. For others, it’s waking up at 2 AM and staring at the ceiling in silence. It’s not just frustrating....

PrimeBiome Blue Antioxidant Method for Skin Reviewed: Discover Side Effects Risk Before Buying

New York City, April 25, 2025 (GLOBE NEWSWIRE) — In This Article, You’ll Discover: How the PrimeBiome Blue Antioxidant Method supports skin health through internal gut balance. Why digestive wellness is key to reducing...

Tevogen Bio Announces 2025 Annual Meeting

WARREN, N.J., April 25, 2025 (GLOBE NEWSWIRE) — Tevogen Bio Holdings Inc. (“Tevogen Bio” or “Company”) (Nasdaq: TVGN) today announced that the Company will hold its 2025 annual meeting of stockholders (the “Annual Meeting”)...

PER® Presents More Than a Dozen Free CME/CE Symposia at the Annual Oncology Meeting in Chicago

CHICAGO, April 25, 2025 (GLOBE NEWSWIRE) — This May, during one of the most important weeks in cancer care, Physicians’ Education Resource®, LLC (PER®), the go-to educational resource for health care professionals across all...

Class Period Expanded in Ready Capital (RC) Securities Class Action, Investors with Losses Encouraged to Contact Hagens Berman Before May 5th Deadline

SAN FRANCISCO, April 25, 2025 (GLOBE NEWSWIRE) — Ready Capital Corporation (NYSE: RC), a New York-based real estate finance firm, is grappling with intensifying investor scrutiny after being named in two securities class-action lawsuits...

Advanced BioNutritionals Under Review: Highly-Trusted Supplement Brand for Quality Products

New York City, April 25, 2025 (GLOBE NEWSWIRE) — In This Article, You’ll Discover: The most common supplement-related health concerns people face today Why supplement quality, formulation, and transparency matter more than ever How...

SightFresh Under Review: Secret Vision Berry to Restore Eyesight with Sight Fresh Ingredients

New York City, April 25, 2025 (GLOBE NEWSWIRE) — In This Article, You’ll Discover: The hidden causes behind the sharp rise in vision problems in 2025 How digital screens, pollution, and aging contribute to...

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Northrop Grumman Corporation – NOC

NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Northrop Grumman Corporation (“Northrop Grumman” or the “Company”) (NYSE: NOC). Such investors are advised to contact...

Enable Injections Presents Survey Results Highlighting Missed Opportunities in Subcutaneous Oncology Drug Development at AACR 2025

CINCINNATI, April 25, 2025 (GLOBE NEWSWIRE) — Enable Injections, Inc. (“Enable”), a healthcare innovation company developing and manufacturing the enFuse® wearable drug delivery platform, announced today the presentation of a poster featuring new findings from a...

Nurix Therapeutics Presents Positive Preclinical Data at the AACR 2025 Annual Meeting from Multiple Orally Available, Brain Penetrant Degraders Against Three High Value Oncology Targets

Nurix’s lead BTK degrader, bexobrutideg, demonstrates exceptional efficiency, with a single molecule degrading approximately 10,000 copies of BTK per hour   BRAF degrader demonstrates broad activity across all three BRAF mutation classes Aurora A kinase...

Bolt Biotherapeutics Presents Results from the Phase 1 Dose-Escalation Clinical Study of BDC-3042 at AACR Annual Meeting 2025

BDC-3042 was well tolerated up to 10 mg/kg q2w with no dose-limiting toxicities and no drug-related serious adverse events BDC-3042 showed biological activity, with clear dose-dependent increases in proinflammatory cytokines and chemokines BDC-3042 showed...

IO Biotech Presents New Data at AACR 2025 Supporting Dual Mechanism and Immune Activation of Cancer Vaccines IO102-IO103 and IO170

Preclinical data further support the potential of dual-antigen and TGF-β-directed vaccines to reshape the tumor microenvironment and drive anti-tumor immunity NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage...

Zymeworks Presents New Data from Multiple Development Programs at 2025 AACR Annual Meeting

Six posters highlight continued progress across antibody-drug conjugate and T cell engager platforms Novel T cell engager ZW209 demonstrates durable activity in small cell lung cancer; IND submission expected in 1H-2026 VANCOUVER, British Columbia,...

DTE Completes Construction on Pine River Solar Park

Detroit, April 25, 2025 (GLOBE NEWSWIRE) — DTE Energy (NYSE:DTE), Michigan’s largest producer of and investor in renewable energy, announced that construction has been completed at Pine River Solar Park during a ribbon-cutting ceremony...

T-knife Therapeutics Presents Preclinical Data at the American Association for Cancer Research (AACR) Annual Meeting Demonstrating a Potential Best-in-Class PRAME Targeted TCR-T Therapy

– TK-6302, a supercharged PRAME targeting TCR-T therapy, demonstrates best-in-class preclinical anti-tumor efficacy as compared to current clinical stage PRAME TCR-T approaches, providing the potential for broad, deep and durable responses in hard-to-treat solid...

Harbinger Health Unveils Promising New Data on Early Cancer Detection Platform at AACR 2025

Novel analytical framework establishes a clinically meaningful performance assessment of blood-based early detection tests Innovative methodology enhances cancer signal detection, boosts specificity and predictive value Presentations further validate the HarbingerHx platform and its utility...

Olema Oncology Announces New Preclinical Data for OP-3136 Demonstrating Anti-Tumor Activity in Multiple Solid Tumor Models at AACR 2025

Activity in preclinical models of ovarian, prostate, and non-small cell lung cancer supports potential utility of OP-3136, a KAT6 inhibitor, in indications beyond breast cancer Patient recruitment ongoing in Phase 1 trial of OP-3136...

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of TechTarget, Inc. – TTGT

NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of TechTarget, Inc. (“TechTarget” or the “Company”) (NASDAQ: TTGT). Such investors are advised to contact Danielle Peyton...

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Uber Technologies, Inc. – UBER

NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Uber Technologies, Inc. (“Uber” or the “Company”) (NYSE: UBER). Such investors are advised to contact Danielle...

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Viatris Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – VTRS

NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Viatris Inc. (NASDAQ: VTRS) between August 8, 2024 and February 26,...

Autolus Therapeutics Announces License of AUCATZYL® (obecabtagene autoleucel) Issued by UK MHRA for Adult Patients (≥ 18 years) with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (R/R B-ALL)(1)

UK Medicines and Healthcare products Regulatory Agency (MHRA) authorisation based on FELIX clinical trial of obecabtagene autoleucel in adult patients with r/r B-ALL1 AUCATZYL® licensed from MHRA under ‘conditional marketing authorisation’, meaning that the...

ReversingLabs Delivers Most Comprehensive Support for CycloneDX xBOM

CAMBRIDGE, Mass., April 25, 2025 (GLOBE NEWSWIRE) — ReversingLabs (RL), the trusted name in file and software security, today announced the launch of leading support for eXtended Bill of Materials (xBOM) capabilities with Spectra...

114 Million Reasons to Keep Moving Forward on Industry-Led Standard for Secure Data Sharing

SALT LAKE CITY, April 25, 2025 (GLOBE NEWSWIRE) — The Financial Data Exchange (FDX) is pleased to report that the use of standardized APIs to enable secure, permissioned data sharing continues to grow. According...